Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionLsv Asset Management
Latest Disclosed Ownership2,892,522 shares
Latest Disclosed Value $ 403,131
Lsv Asset Management reports 30.24% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - Lsv Asset Management filed a 13F-HR form disclosing ownership of 2,892,522 shares of Gilead Sciences, Inc. (US:GILD) valued at $403,130,791 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 4,146,280 shares of Gilead Sciences, Inc.. This represents a change in shares of -30.24% during the quarter. The current value of the position is $373,135,338 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Gilead Sciences COM 375558103 2,892,522 -1,253,758 -30.24 403 -20.67 0.8687
2026-02-06 2025-12-31 13F Gilead Sciences COM 375558103 4,146,280 -153,313 -3.57 509 6.50 1.1098
2025-11-06 2025-09-30 13F Gilead Sciences COM 375558103 4,299,593 -218,077 -4.83 477 -4.60 1.0539
2025-08-11 2025-06-30 13F Gilead Sciences COM 375558103 4,517,670 -402,120 -8.17 501 -9.26 1.1725
2025-05-09 2025-03-31 13F Gilead Sciences COM 375558103 4,919,790 -108,708 -2.16 551 18.75 1.3231
2025-02-13 2024-12-31 13F Gilead Sciences COM 375558103 5,028,498 -259,370 -4.91 464 4.74 1.0722
2024-11-12 2024-09-30 13F Gilead Sciences COM 375558103 5,287,868 -222,021 -4.03 443 17.20 0.9502
2024-08-06 2024-06-30 13F Gilead Sciences COM 375558103 5,509,889 -166,860 -2.94 378 -8.92 0.8282
2024-05-06 2024-03-31 13F Gilead Sciences COM 375558103 5,676,749 -251,250 -4.24 416 -13.54 0.8604
2024-02-06 2023-12-31 13F Gilead Sciences COM 375558103 5,927,999 -210,210 -3.42 480 4.58 1.0479
2023-11-03 2023-09-30 13F Gilead Sciences COM 375558103 6,138,209 -154,260 -2.45 460 -5.17 1.0700
2023-08-02 2023-06-30 13F Gilead Sciences COM 375558103 6,292,469 -192,260 -2.96 485 -10.04 1.0693
2023-05-02 2023-03-31 13F Gilead Sciences COM 375558103 6,484,729 -80,949 -1.23 538 -4.44 1.2067
2023-02-08 2022-12-31 13F Gilead Sciences COM 375558103 6,565,678 -116,851 -1.75 564 -99.86 1.2430
2022-11-07 2022-09-30 13F/A-1 Gilead Sciences COM 375558103 6,682,529 135,802 2.07 412,245 1.88 0.9685
2022-11-04 2022-09-30 13F Gilead Sciences COM 375558103 6,546,727 0 404,653 0.8750
2022-08-10 2022-06-30 13F Gilead Sciences COM 375558103 6,546,727 998,538 18.00 404,653 22.68 0.8750
2022-05-12 2022-03-31 13F Gilead Sciences COM 375558103 5,548,189 445,089 8.72 329,840 -10.98 0.6055
2022-01-28 2021-12-31 13F Gilead Sciences COM 375558103 5,103,100 769,409 17.75 370,536 22.41 0.6562
2021-11-04 2021-09-30 13F Gilead Sciences COM 375558103 4,333,691 170,913 4.11 302,708 5.60 0.5472
2021-08-04 2021-06-30 13F Gilead Sciences COM 375558103 4,162,778 -25,672 -0.61 286,648 5.89 0.4874
2021-04-30 2021-03-31 13F Gilead Sciences COM 375558103 4,188,450 -200,200 -4.56 270,699 5.87 0.4624
2021-02-08 2020-12-31 13F Gilead Sciences COM 375558103 4,388,650 -193,500 -4.22 255,682 -11.70 0.4647
2020-10-23 2020-09-30 13F Gilead Sciences COM 375558103 4,582,150 69,982 1.55 289,546 -16.60 0.5923
2020-08-05 2020-06-30 13F Gilead Sciences COM 375558103 4,512,168 16,944 0.38 347,166 3.30 0.7197
2020-05-07 2020-03-31 13F Gilead Sciences COM 375558103 4,495,224 -92,467 -2.02 336,062 12.73 0.8120
2020-02-10 2019-12-31 13F Gilead Sciences COM 375558103 4,587,691 54,747 1.21 298,108 3.76 0.4646
2019-11-07 2019-09-30 13F Gilead Sciences COM 375558103 4,532,944 -123,000 -2.64 287,297 -8.67 0.4750
2019-08-08 2019-06-30 13F/A-1 Gilead Sciences COM 375558103 4,655,944 -30,557 -0.65 314,555 3.24 0.5068
2019-08-07 2019-06-30 13F Gilead Sciences COM 375558103 4,686,501 0 304,669
2019-05-07 2019-03-31 13F Gilead Sciences COM 375558103 4,686,501 37,464 0.81 304,669 4.77 0.4880
2019-02-05 2018-12-31 13F Gilead Sciences COM 375558103 4,649,037 -65,866 -1.40 290,797 -20.12 0.5166
2018-11-06 2018-09-30 13F Gilead Sciences COM 375558103 4,714,903 4,399 0.09 364,037 9.09 0.5445
2018-08-08 2018-06-30 13F Gilead Sciences COM 375558103 4,710,504 44,427 0.95 333,692 -5.14 0.5219
2018-05-04 2018-03-31 13F Gilead Sciences COM 375558103 4,666,077 106,380 2.33 351,775 7.69 0.5587
2018-01-31 2017-12-31 13F Gilead Sciences COM 375558103 4,559,697 906,959 24.83 326,656 10.38 0.5156
2017-11-13 2017-09-30 13F Gilead Sciences COM 375558103 3,652,738 1,398,048 62.01 295,944 85.44 0.4882
2017-08-09 2017-06-30 13F Gilead Sciences COM 375558103 2,254,690 24,046 1.08 159,586 5.33 0.2842
2017-05-01 2017-03-31 13F Gilead Sciences COM 375558103 2,230,644 36,257 1.65 151,505 -3.59 0.2761
2017-02-07 2016-12-31 13F Gilead Sciences COM 375558103 2,194,387 170,310 8.41 157,140 -1.88 0.2892
2016-11-07 2016-09-30 13F Gilead Sciences COM 375558103 2,024,077 36,780 1.85 160,144 -3.40 0.3145
2016-08-05 2016-06-30 13F Gilead Sciences COM 375558103 1,987,297 174,660 9.64 165,780 -0.44 0.3392
2016-05-10 2016-03-31 13F Gilead Sciences COM 375558103 1,812,637 82,980 4.80 166,508 -4.87 0.3489
2016-02-03 2015-12-31 13F Gilead Sciences COM 375558103 1,729,657 66,061 3.97 175,023 7.15 0.3799
2015-11-05 2015-09-30 13F Gilead Sciences COM 375558103 1,663,596 546,110 48.87 163,348 24.85 0.3664
2015-08-07 2015-06-30 13F Gilead Sciences COM 375558103 1,117,486 704,786 170.77 130,835 223.07 0.2713
2015-05-06 2015-03-31 13F Gilead Sciences COM 375558103 412,700 412,700 0.00 40,498 0.0841
2015-02-04 2014-12-31 13F Gilead Sciences COM 375558103 0 -342,700 -100.00 0 -100.00
2014-11-12 2014-09-30 13F Gilead Sciences COM 375558103 342,700 191,100 126.06 36,480 190.24 0.0799
2014-08-06 2014-06-30 13F Gilead Sciences COM 375558103 151,600 151,600 3,509.52 12,569 4,679.09 0.0279
2014-02-05 2013-12-31 13F Gilead Sciences COM 375558103 0 -4,200 -100.00 0 -100.00
2013-11-08 2013-09-30 13F Gilead Sciences COM 375558103 4,200 4,200 263 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.